Trials / Completed
CompletedNCT01635881
Evaluation of Coronary Luminal Diameter Enlargement With Emerge™ 1.20 mm PTCA Dilatation Catheter
EMERGE: Evaluation of Coronary Luminal Diameter Enlargement With Emerge™ 1.20 mm Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilatation Catheter
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the acute safety and device procedural success of the Emerge 1.20 mm PTCA dilatation catheter when used as a pre-dilatation device in the stenotic portion of coronary arteries or bypass grafts.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Emerge™ 1.20 mm PTCA Dilatation Catheter | The Emerge 1.20 mm device is the next-generation Boston Scientific PTCA dilatation catheter. It is a sterile, single-use, intravascular medical device used to improve lumen diameter. The catheter consists of a shaft with a balloon near the distal tip. The balloon is designed to provide an inflatable segment of known diameter and length at recommended pressures. |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2012-07-10
- Last updated
- 2013-11-06
- Results posted
- 2013-11-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01635881. Inclusion in this directory is not an endorsement.